The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...